pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Jun 9·1 min read
save

ADA ejects five diabetes experts for distributing editorial criticizing NIH research cuts

Jun 9, 2026·read at STAT ↗Negative

Security personnel removed five diabetes researchers from the American Diabetes Association's annual meeting in New Orleans after they handed out copies of an editorial that condemned recent federal cuts to biomedical research.

The expulsions have sparked outrage among the diabetes community, with senior figures demanding an apology from the ADA or a change in its leadership, fearing damage to the organization’s credibility and to diabetes care.

The protest was directed at funding reductions tied to policies of the Trump administration and at NIH director Jay Bhattacharya, who had been scheduled to deliver the keynote address before withdrawing.

John Buse, a former ADA president and co‑author of the editorial, described the incident as "inconceivable," underscoring the depth of disappointment among experts.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Diabetes Association in uproar after members expelled from annual meeting over protest of NIH cuts”

read at STAT ↗
1,290 words · retrieved Jun 9
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
LEADING2ASTRAZENECAGILEADNational Institutes of Health
drugs
Obesity
topics
Type 2 Diabetes16Cardiology4Endocrinology & Metabolism2Obesity

related stories

  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive
  • Jun 10Diabetes association leader apologizes for expulsion of members, pledges to rebuild trustSTAT
  • Dec 22Fierce Biotech Fundraising Tracker '26: Superluminal snags $60M; AusperBio adds $120MFierce Biotech
  • 17h ago‘Tactical athletes’ get new guidance for cardiovascular fitnessSTAT
  • 2d agoSTAT+: ADA review of members’ expulsion denies group censored opinions, called in policeSTAT